According to the NHS, symptoms may involve your ability to pay attention to things, having high energy, or being unable to ...

Attention-deficit/hyperactivity disorder in childhood is associated with a high probability of multimorbidity and health-related disability in midlife, a new cohort study shows.

Attention-deficit/hyperactivity disorder is one of the most researched neurodevelopmental conditions, yet 5 ADHD myths people ...

FDA fast tracks ADHD drug centanafadine, targeting approval by July 24 for treatment across all age groups, based on phase 3 trial results.

Attention-Deficit Hyperactivity Disorder, or ADHD, affects tens of millions of people in the U.S.About one in nine children ...

The FDA has started a priority review of Otsuka Pharma's triple-acting drug for attention-deficit hyperactivity disorder ...

The hyperactivity disorder, usually referred to as ADHD, is an independent risk factor for several common and serious mental health issues, finds research published in the open access journal BMJ ...

UK had highest relative increase of five countries in study, with 20-fold rise in proportion of women over 25 using it ...

With an expiration date still more than a year away, here's what the latest details reveal.

Too much executive functioning is expected from ADHD-ers, ignoring key struggles of the disability. Colleges and universities ...

General practitioners in Victoria will soon be able to diagnose and treat ADHD in adults and children, in a move the state ...

A new, large-scale independent UK clinical trial involving 150 children and teenagers found no evidence that TNS improved ...